Medtronic Plc MDT has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional Atherectomy ...
Medtronic has recalled the TurboHawk Plus directional atherectomy system, used in the peripheral arteries, due to the risk of catheter-tip damage during use, the US Food and Drug Administration ...
The TurboHawk features a four angled super cutter blade that are designed to provide an efficient directional atherectomy tool for above the knee interventions including severally calcified lesions ...
The latest recall includes 686 devices in the U.S., distributed after the TurboHawk Plus received an FDA clearance in August 2021. (Medtronic) Medtronic and the FDA are expanding the reach of a Class ...
Study Confirms Effectiveness of Directional Atherectomy with SilverHawk ™ and TurboHawk ™ Devices as a Frontline Therapy when Treating PAD LAS VEGAS--(BUSINESS WIRE)-- Covidien (NYSE:COV), a leading ...
Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...
Covidien Announces Final Results from Landmark DEFINITIVE LE Study in Patients with Peripheral Arter
DEFINITIVE LE study confirms that directional atherectomy with Covidien's TurboHawk(TM) device is an ... DEFINITIVE LE study confirms that directional atherectomy with Covidien's TurboHawk(TM) device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results